MSB 12.1% 55.5¢ mesoblast limited

Cell Therapy News/Articles, page-47

  1. 3,702 Posts.
    lightbulb Created with Sketch. 1263
    This keeps going round in circles. Yes that trial failed. There is a useful article to read, it covers some of the factors that may not have not been properly controlled to ensure optimal performance and there are a number of them.

    The Mesoblast product and its' application/selection criteria has had over a half a decade of refinement, just maybe it will perform more reliably.

    http://stemcellassays.com/2013/01/failure-mesenchymal-stem-cells-gvhd-devil-cell-prep/
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
55.5¢
Change
0.060(12.1%)
Mkt cap ! $633.0M
Open High Low Value Volume
50.0¢ 59.0¢ 48.5¢ $16.88M 30.80M

Buyers (Bids)

No. Vol. Price($)
7 99223 55.5¢
 

Sellers (Offers)

Price($) Vol. No.
56.0¢ 44000 4
View Market Depth
Last trade - 16.10pm 28/03/2024 (20 minute delay) ?
Last
55.5¢
  Change
0.060 ( 15.7 %)
Open High Low Volume
50.5¢ 59.0¢ 48.5¢ 11524458
Last updated 16.02pm 28/03/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.